and general health of the individual patient the severity of the soreness the particular chemical formulation and the like the chemical formulation typically includes about 5 to 15 of magnesium chloride by weight about 2 to 10 of guaifenesin by weight and about 2 to 10 of methylsufonylmethane by weight these three ingredients are combined with a liposomal base delivery agent the base delivery agent prescription grade formulation includes guaifenesin greater than 4 table 1 describes an embodiment of the chemical formulation as implemented into a liposomal cream base that can be topically administered to a host the preferred embodiment of the cream formulation includes approximately 10 percent by weight of the magnesium compound the cream formulation can be topically administered into the host by externally rubbing a sufficient amount of the cream over the target muscle or muscle groups typically about 1 to 2 grams of cream is a sufficient amount to reduce muscle and joint soreness however this varies with the size of the host and the target muscle group a sufficient amount of cream is applied externally to cover the target muscle or muscle groups for treatment typically a sufficient amount of cream is topically administered at least 3 three times per day or within a 24 hour period additional cream can be topically administered for hosts with.